Development and validation of a method for quantifying atorvastatin tablets by HPLC-DAD

Authors

  • Joseline Iveth Funes Estudiante de la Carrera de Química y Farmacia, Facultad de Química y Farmacia, UNAH
  • Meidy Nairoby Meza Estudiante de la Carrera de Química y Farmacia, Facultad de Química y Farmacia, UNAH
  • Henry Daniel Ponce Asesor, Departamento de Control Químico, Facultad de Química y Farmacia, UNAH

DOI:

https://doi.org/10.5377/pc.v9i0.2670

Keywords:

atorvastine, HPLC, validation, tablets

Abstract

A method for the identification and determination of Atorvastatine (ATO) in tablets by high performance liquid chromatography with diode array detector (HPLC-DAD) is proposed. Better separation of the analyte was optimized with a gradient isocratic separation by using a mobile phase composed of water adjusted to pH 3.0 with orto phosphoric acid and acetonitrile (50:50). The separation of the analyte was achieved using a C18 column 150 X 4 mm with a particle size of 5microns at a temperature of 40°C and a 245nm detector wavelength. The method was validated following the recommendations made by the International Conference of Harmonization (ICH), showing good linear relationships for the analyte (r greater than 0.998). The precision and accuracy of the results intra and inter-day was between 98.0 and 102%. The proposed method was applied successfully to the determination of the compound in pharmaceutical preparations of tablets with good accuracy and precision (without interference excipients), with which the method can be applied to routine analysis based compound.

Revista Portal de la Ciencia, No. 9, diciembre 2015, pp.27-41

Downloads

Download data is not yet available.
Abstract
1363
PDF (Español (España)) 3732

Published

2016-06-15

How to Cite

Funes, J. I., Meza, M. N., & Ponce, H. D. (2016). Development and validation of a method for quantifying atorvastatin tablets by HPLC-DAD. Portal De La Ciencia, 9, 27–41. https://doi.org/10.5377/pc.v9i0.2670

Issue

Section

Area Life Sciences and Health